Meta-analysis shows GLP-1 receptor agonists reduce ischemic stroke incidence and improve post-stroke outcomes in diabetes patients, adding stroke protection to their cardiovascular benefits.
Key findingMeta-analysis shows GLP-1 receptor agonists reduce ischemic stroke incidence and improve post-stroke
What the researchers found
Meta-analysis shows GLP-1 receptor agonists reduce ischemic stroke incidence and improve post-stroke outcomes in diabetes patients, adding stroke protection to their cardiovascular benefits.
Why it matters
This finding has implications for the millions of patients using or considering peptide-based therapies.
The numbers in context
Meta-analysis of randomized controlled trials showed significant reductions in both stroke and MI incidence with GLP-1 drugs, with stroke protection being more pronounced.
How the study worked
Clinical or preclinical study with methodology detailed in the full publication.
Who was studied
Adults in cardiovascular outcome trials comparing GLP-1 drugs to placebo
What this study cannot tell us
Study-specific limitations are discussed in the full publication. As with all research, findings should be interpreted in the context of study design and population.
How to read the evidence
Evidence grade assessment based on study design and methodology detailed in the full publication.
When this study was published
Published in 2025. Reflects current state of peptide therapeutic research.
The bigger picture
This study adds to the rapidly expanding evidence base for peptide-based therapeutics across multiple medical specialties.
Questions still open
- What are the long-term implications of these findings?
- How do these results compare to other studies in this area?
- What further research is needed to confirm and extend these findings?
Common questions
What does this study mean for patients?
How reliable are these findings?
Read the original research
Effects of GLP-1 receptor agonists on incidence and outcomes of ischemic stroke and myocardial infarction: A systematic review and meta-analysis.
Diabetes, obesity & metabolism, 27(8), 4387-4400
Citation
Alammari, Nawal; Alshehri, Atheel; Al Khalaf, Abdulhameed; Alamri, Rahaf Abdulaziz; Alhalal, Noor; Sultan, Majd Abdullah; Ogran, Nesreen; Aljohani, Razan Mubarak S; Alasmari, Sarah Mohammed Saad; Alsharif, Sarah Badr; Al-Qahtani, Zainah; Azzam, Ahmed Y. (2025). Effects of GLP-1 receptor agonists on incidence and outcomes of ischemic stroke and myocardial infarction: A systematic review and meta-analysis.. Diabetes, obesity & metabolism, 27(8), 4387-4400. https://doi.org/10.1111/dom.16476